Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

1. Ciruelos, E.
2. Jerusalem, G.
3. Martin, M.
4. Tjan-Heijnen, V.C.G.
5. Neven, P.
6. Gavila, J.
7. Montemurro, F.
8. Generali, D.
9. Lang, I.
10. Martínez-Serrano, M.J.
11. Perelló, M.F.
12. Conte, P.